Home › Pneumococcal Infections › Missouri
Pneumococcal Infections clinical trials in Missouri
3 studies for Pneumococcal Infections are looking for participants at sites in Missouri.
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
- Clinical Research Professionals, Chesterfield
- Bio-Kinetic Clinical Applications, LLC dba QPS-MO, Springfield
- Bio-Kinetic Clinical Applications, LLC dba QPS-MO-Screening and Recruitment Center, Springfield
- and 1 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 49 · All sexes · Updated Sep 23, 2026 · NCT07794748A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
- University of Missouri Pediatrics Clinic-South Providence, Columbia
- University of Missouri, Columbia
RecruitingPhase 3Healthy volunteers welcome
42 Days – 211 Days · All sexes · Updated Sep 8, 2026 · NCT07629440A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
- Saint Louis University Center for Vaccine Development ( Site 1031), St Louis
RecruitingPhase 1Healthy volunteers welcome
2 Months – 15 Months · All sexes · Updated Apr 17, 2026 · NCT07300267From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.